We are live on
!
Find out more
EDRH
Edmond de Rothschild Holding Portfolio holdings
AUM
$6.91B
1-Year Est. Return
19.7%
This Fund
S&P 500
This Quarter
Est. Return
+10.04%
1 Year Est. Return
+19.7%
3 Year Est. Return
+58.62%
5 Year Est. Return
+75.86%
10 Year Est. Return
+280.23%
AUM
$2.53B
AUM Growth
+$33.6M
(+1.3%)
Cap. Flow
-$297M
Cap. Flow
% of AUM
-11.73%
Top 10 Holdings %
Top 10 Hldgs %
21.8%
Holding
624
New
43
Increased
140
Reduced
170
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Akamai
AKAM
|
+$11.8M |
| 2 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$11.2M |
| 3 |
Logitech
LOGI
|
+$8.45M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$8.28M |
| 5 |
MIME
Mimecast Limited
MIME
|
+$7.48M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$36.2M |
| 2 |
Qiagen
QGEN
|
+$26.2M |
| 3 |
AGN
Allergan plc
AGN
|
+$23.2M |
| 4 |
Johnson & Johnson
JNJ
|
+$14.1M |
| 5 |
JPMorgan Chase
JPM
|
+$13.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.48% |
| 2 | Financials | 15.69% |
| 3 | Technology | 12.19% |
| 4 | Communication Services | 8.81% |
| 5 | Energy | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
CVS Health
CVS
$137B
| $66.7M | 2.63% |
898,260
-120,000
| -12% | -$8.43M |
|
2
Bank of America
BAC
$436B
| $65.7M | 2.59% |
1,866,588
-324,980
| -15% | -$10.5M |
|
3
IBM
IBM
$204B
| $60.7M | 2.4% |
473,627
+24,617
| +5% | +$3.2M |
|
4
State Street SPDR S&P 500 ETF Trust
SPY
$781B
| $60.6M | 2.39% |
188,142
-19,695
| -9% | -$6.06M |
|
5
Alibaba
BABA
$276B
| $59M | 2.33% |
278,060
-2,624
| -0.9% | -$492K |
|
6
Gilead Sciences
GILD
$162B
| $56.8M | 2.24% |
874,359
-88,389
| -9% | -$5.76M |
|
7
Alphabet (Google) Class A
GOOGL
$3.99T
| $49.4M | 1.95% |
738,080
+15,440
| +2% | +$996K |
|
|
8
JPMorgan Chase
JPM
$947B
| $45M | 1.77% |
322,562
-107,587
| -25% | -$13.8M |
|
9
AT&T
T
$167B
| $44.3M | 1.75% |
1,501,807
-268,738
| -15% | -$7.76M |
|
10
Microsoft
MSFT
$2.89T
| $44.3M | 1.75% |
280,613
+5,771
| +2% | +$848K |
|
11
Pfizer
PFE
$141B
| $42.8M | 1.69% |
1,151,025
-68,109
| -6% | -$2.43M |
|
12
Merck
MRK
$323B
| $42.4M | 1.67% |
488,730
-48,876
| -9% | -$4.01M |
|
13
American International
AIG
$42B
| $39.6M | 1.56% |
770,693
+115,600
| +18% | +$6.13M |
|
14
Citigroup
C
$223B
| $37.6M | 1.48% |
470,380
-111,051
| -19% | -$8.21M |
|
15
Verizon
VZ
$198B
| $35.9M | 1.42% |
583,995
-29,991
| -5% | -$1.81M |
|
16
MetLife
MET
$61.2B
| $35.8M | 1.41% |
702,382
-165,752
| -19% | -$8M |
|
17
Amazon
AMZN
$2.49T
| $35M | 1.38% |
379,160
-47,680
| -11% | -$4.22M |
|
18
iShares Core S&P Mid-Cap ETF
IJH
$123B
| $30.1M | 1.19% |
731,650
-27,970
| -4% | -$1.11M |
|
19
SPDR Gold Trust
GLD
$132B
| $29.5M | 1.17% |
206,597
-13,083
| -6% | -$1.83M |
|
20
Chevron
CVX
$378B
| $29.3M | 1.16% |
243,216
+10,338
| +4% | +$1.22M |
|
21
Centene
CNC
$31.6B
| $28.2M | 1.11% |
448,147
-11,975
| -3% | -$650K |
|
|
22
Qiagen
QGEN
$8.47B
| $27.2M | 1.07% |
748,863
-705,893
| -49% | -$26.2M |
|
23
Zimmer Biomet
ZBH
$17.8B
| $27.1M | 1.07% |
186,299
-15,146
| -8% | -$2.09M |
|
24
NOV
NOV
$7.35B
| $26.2M | 1.03% |
1,044,579
-61,145
| -6% | -$1.38M |
|
25
Check Point Software Technologies
CHKP
$13.6B
| $25.7M | 1.01% |
231,424
+62,039
| +37% | +$6.97M |
|
Similar funds
AMH
AG
PFA
RBI
STA
SBH
GAM
DE
Edmond de Rothschild Holding's Q4 2019 Portfolio in Review
As of Q4 2019, Edmond de Rothschild Holding held 624 positions worth $2.53B, up 1.3% from $2.5B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Edmond de Rothschild Holding withdrew a net $297M in Q4 2019, closing 43 positions and reducing 170 holdings. Its most notable exit was Celgene Corp, an estimated $9.87M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 23% a quarter earlier, followed by Financials and Technology.
Against the trend, Edmond de Rothschild Holding opened a new position in Vanguard FTSE All-World ex-US ETF worth $11.6M.
- Edmond de Rothschild Holding's largest Q4 2019 buy was Vanguard FTSE All-World ex-US ETF: 216,131 shares worth $11.6M.
- Edmond de Rothschild Holding added most to Akamai in Q4 2019, an estimated $11.8M increase.
- Edmond de Rothschild Holding's biggest Q4 2019 reduction was iShares 7-10 Year Treasury Bond ETF, cutting an estimated $36.2M.
- Edmond de Rothschild Holding fully exited Celgene Corp in Q4 2019, selling an estimated $9.87M.
- Edmond de Rothschild Holding's ten largest holdings make up 22% of its $2.53B portfolio in Q4 2019.
- Edmond de Rothschild Holding opened 43 new positions and closed 43 in Q4 2019.
- Edmond de Rothschild Holding's portfolio value rose 1.3% quarter-over-quarter to $2.53B.
Based on Edmond de Rothschild Holding's 13F filing for Q4 2019, filed 14 Feb 2020.